Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

Share Price is delayed by 15 minutes
Get Live Data
80.00    0.20 (0.25%)
Bid:
79.50
Ask:
80.00
Spread: 0.50 (0.629%)
Market Cap: £131.15m
SYNT Live PriceLast checked at - London Stock Exchange

Intraday Synthomer Share Chart

Receivables purchasing arrangement

18 Dec 2025 07:00

RNS Number : 0195M
Synthomer PLC
18 December 2025
 

Synthomer plcReceivables purchasing arrangement

 

Synthomer plc ('Synthomer' or the 'Company') today announces that it has entered into a trade receivables purchasing arrangement with Rainbow State Limited, a subsidiary of its largest shareholder Kuala Lumpur Kepong Berhad Group ('KLK'). The Company has put this temporary arrangement in place with the support of KLK to provide additional short-term financial flexibility and ensure a prudent level of banking covenant headroom at year end.

 

Under the arrangement, the Company and KLK have agreed that KLK will purchase c.£50m of Company trade receivables due on or before 28 February 2026, which are not eligible for inclusion in the Company's existing committed €200m non-recourse receivables financing facility. It is anticipated that receivables purchased under the arrangement and in the existing committed receivables financing facility together will not exceed €200m (c.£175m). The purchasing arrangement terms have been agreed on an arms-length basis and are consistent with terms available from third party market participants for an arrangement of this nature.

 

Related party transaction

By virtue of KLK and its connected parties' c.27 per cent shareholding in Synthomer, KLK is considered a related party of Synthomer under the UK Listing Rules. The board of Synthomer (excluding Dato' Lee Hau Hian and Uwe Halder by reason of their relationship with KLK) considers that the purchasing arrangement is fair and reasonable as far as Synthomer shareholders are concerned, and have been so advised by Rothschild & Co acting in its capacity as sponsor in relation to this related party transaction.

 

Post-close trading update

Synthomer plans to publish its post-close trading update for the year ending 31 December 2025 in late January.

 

 

Further information:

Investors: Faisal Tabbah, Vice President Investor Relations

Tel: +44 (0) 1279 775 306

Media: Nick Hasell, FTI Consulting

Tel: +44 (0) 203 727 1340

 

Notes

Synthomer plc is a leading supplier of high-performance, highly specialised polymers and ingredients that play vital roles in key sectors such as coatings, construction, adhesives, and health and protection - growing markets for customers who serve billions of end users worldwide. Headquartered in London, UK and listed there since 1971, we employ c.3,800 employees across our five innovation centres of excellence and 29 manufacturing sites across Europe, North America, Middle East and Asia. With more than 6,000 blue-chip customers and £2.0bn in continuing revenue in 2024, our business is built around three divisions, serving customers in attractive end markets where demand is driven by global megatrends including urbanisation, demographic change, climate change and sustainability, and shifting economic power.

 

In Coatings & Construction Solutions, our specialist polymers enhance the sustainability and performance of a wide range of coatings and construction products. We serve customers in applications including architectural and masonry coatings, mortar modification, waterproofing and flooring, fibre bonding, and energy solutions. In Adhesive Solutions our products help our customers bond, modify and compatibilise surfaces and components for applications including tapes and labels, packaging, hygiene, tyres and plastic modification, improving permeability, strength, elasticity, damping, dispersion and grip. In Health & Protection and Performance Materials we are a world-leading supplier of water-based polymers for medical gloves, and a major European manufacturer of high-performance binders, foams and other products serving customers in a range of end markets.

 

Our purpose is creating innovative and sustainable solutions for the benefit of customers and society. Around 20% of our sales volumes are from new and patent protected products. At our innovation centres of excellence in the UK, China, Germany, Malaysia and Ohio, USA we collaborate closely with our customers to develop new products and enhance existing ones tailored to their needs, with an increasing range of sustainability benefits. Our 2030 decarbonisation targets have been approved by the Science Based Targets initiative as being in line with what the latest climate science says is necessary to meet the goals of the Paris Agreement, and since 2021 we have held the London Stock Exchange Green Economy Mark, which recognises green technology businesses making a significant contribution to a more sustainable, low-carbon economy. Find us at www.synthomer.com or search for Synthomer on LinkedIn.

 

N. M. Rothschild and Sons Limited ('Rothschild & Co'), which is authorised and regulated by the FCA in the United Kingdom, is acting exclusively for the Company and no one else in connection with the receivables purchasing arrangement and will not be responsible to any other person for providing the protections afforded to its clients or for providing advice in connection with the receivables purchasing arrangement, the contents of this announcement or any other matter referred to herein.

 

Apart from the responsibilities and liabilities, if any, which may be imposed on Rothschild & Co by the FSMA or the regulatory regime established thereunder, or under the regulatory regime of any jurisdiction where the exclusion of liability under the relevant regulatory regime would be illegal, void or unenforceable, neither Rothschild & Co nor any of its affiliates (nor their respective directors, officers, employees or agents) owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Rothschild & Co in connection with this announcement, any statement contained herein, the receivables purchasing arrangement or otherwise. Rothschild & Co. accepts no responsibility whatsoever for, or makes any representation or warranty, express or implied, as to the contents of this announcement, including its accuracy, completeness or verification or for any other statement made or purported to be made by it, or on its behalf, and nothing contained in this document is, or shall be, relied on as a promise or representation in this respect, whether as to the past or the future, in connection with the Company or the receivables purchasing arrangement. Rothschild & Co. and its respective subsidiaries, branches and affiliates accordingly disclaim, to the fullest extent permitted by law, all and any duty, liability and responsibility whether arising in tort, contract or otherwise (save as referred to above) in respect of this announcement or any such statement or otherwise.

 

Legal Entity Identifier (LEI): 213800EHT3TI1KPQQJ56.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGRFZMMZRNVGKZM
Date   Source Headline
12th Nov 20135:06 pmRNSHolding(s) in Company
8th Nov 20133:03 pmRNSHolding(s) in Company
7th Nov 20137:00 amRNSInterim Management Statement
29th Oct 20131:45 pmRNSHolding(s) in Company
14th Oct 20133:55 pmRNSHolding(s) in Company
22nd Aug 201311:18 amRNSHolding(s) in Company
16th Aug 201312:36 pmRNSDirector/PDMR Shareholding
13th Aug 20137:00 amRNSInterim Results
12th Aug 20131:37 pmRNSHolding(s) in Company
7th Aug 20133:18 pmRNSHolding(s) in Company
4th Jul 20133:37 pmRNSHolding(s) in Company
28th Jun 20134:21 pmRNSHolding(s) in Company
6th Jun 201310:46 amRNSHolding(s) in Company
17th May 20134:33 pmRNSHolding(s) in Company
16th May 20131:07 pmRNSResult of AGM
16th May 20137:00 amRNSInterim Management Statement
2nd May 20134:59 pmRNSHolding(s) in Company
24th Apr 20134:37 pmRNSDirector/PDMR Shareholding
24th Apr 20134:36 pmRNSDirector/PDMR Shareholding
24th Apr 201311:14 amRNSHolding(s) in Company
16th Apr 201311:52 amRNSReplacement Annual Financial Report
16th Apr 20139:29 amRNSAnnual Financial Report
15th Apr 20131:58 pmRNSHolding(s) in Company
9th Apr 201311:52 amRNSDirector/PDMR Shareholding
28th Mar 20139:19 amRNSHolding(s) in Company
19th Mar 20134:31 pmRNSHolding(s) in Company
15th Mar 20137:00 amRNSPreliminary Results
14th Feb 20131:59 pmRNSReplacement Director Declaration
14th Feb 20131:00 pmRNSDirectorate Change
13th Feb 201311:23 amRNSHolding(s) in Company
7th Feb 201312:26 pmRNSDirectorate Change
1st Feb 20134:37 pmRNSDirector Declaration
19th Dec 201210:08 amRNSReplacement Holding(s) in Company
17th Dec 201210:11 amRNSDirector Declaration
14th Dec 201212:38 pmRNSReplacement Holding(s) in Company
14th Dec 201212:27 pmRNSDirector Declaration
6th Dec 20124:35 pmRNSHolding(s) in Company
4th Dec 201212:17 pmRNSResult of EGM
16th Nov 201211:34 amRNSDirector Declaration
8th Nov 20127:00 amRNSNotice of General Meeting
8th Nov 20127:00 amRNSInterim Management Statement
1st Nov 201212:28 pmRNSHolding(s) in Company
12th Oct 20124:15 pmRNSHolding(s) in Company
5th Oct 20127:00 amRNSDirectorate Change
27th Sep 20122:24 pmRNSHolding(s) in Company
25th Sep 20124:06 pmRNSHolding(s) in Company
10th Sep 20123:38 pmRNSDirector Declaration
6th Sep 20128:58 amRNSHolding(s) in Company
28th Aug 20127:00 amRNSInterim Results 2012
22nd Aug 20125:06 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.